Trial intelligence / Profile preview

Intravenous phosphorus versus oral phosphate for hypophosphatemia in critically ill adults

IRCT20150107020592N18Phase 3Completed

Sponsor
Masih Daneshvari Hospital
Start
Mar 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in hypophosphatemia and phosphorus metabolism disorder comparing Oral phosphate with Intravenous phosphorus (2 arms). Started Mar 2016; status: completed.

02

Drugs

phosphorusphosphate
03

Conditions

hypophosphatemiaphosphorus metabolism disorder

Beyond the preview

Go deeper on IRCT20150107020592N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150107020592N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call